Jeanette Leusen

Professor at Jeanette Leusen's lab @UMC Utrecht
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Utrecht, Utrecht, Netherlands, NL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Netherlands
    • Research Services
    • 1 - 100 Employee
    • Professor
      • Sep 2023 - Present
    • Biotechnology Research
    • Senior advisor and scientific founder
      • Jun 2022 - Present

    • CSO and scientific founder
      • Sep 2018 - Jul 2022

    • Research Services
    • 1 - 100 Employee
    • Workstream leader Biologics of Oncode Accelerator
      • Jun 2022 - Present
    • Principal Investigator
      • Jan 2005 - Present

      Head of Immunotherapy lab Fc Receptors and antibody therapy Head of Immunotherapy lab Fc Receptors and antibody therapy

    • Assistant Professor
      • Jan 2002 - Jan 2005

    • Post doctoral fellow
      • Oct 1998 - Jan 2002

      Biology of the high affinity Fc gamma receptor or CD64

    • Post doc
      • 1995 - 1998

      cytotoxic T cells cytotoxic T cells

    • Netherlands
    • Hospitals and Health Care
    • 700 & Above Employee
    • PhD student
      • 1991 - 1995

      Study the components of the human neutrophil NADPH oxidase, impact on Chronic Granulomatous Disease (CGD) Study the components of the human neutrophil NADPH oxidase, impact on Chronic Granulomatous Disease (CGD)

    • Netherlands
    • Mental Health Care
    • 200 - 300 Employee
    • undergraduate student
      • 1988 - 1989

      Isolate the auto antigen for Wegener's disease, proteinase 3, from purulent sputum Isolate the auto antigen for Wegener's disease, proteinase 3, from purulent sputum

Education

  • University of Amsterdam
    PhD, Immunology/Cell Biology
    1991 - 1995
  • Leiden University
    MSc, Medical Biology
    1984 - 1991

Community

You need to have a working account to view this content. Click here to join now